QNCX icon

Quince Therapeutics

61 hedge funds and large institutions have $12.4M invested in Quince Therapeutics in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

less ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

52% less capital invested

Capital invested by funds: $26M → $12.4M (-$13.6M)

54% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 26

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$361K
Puts
$403K
Net Calls
Net Calls Change

Top Buyers

1 +$650K
2 +$150K
3 +$146K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$112K
5
Renaissance Technologies
Renaissance Technologies
New York
+$72.9K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$75K
27
$61K
28
$61K
29
$48K
30
$44K
31
$41K
32
$39K
33
$36K
34
$36K
35
$28K
36
$23K
37
$20K
38
$18K
39
$17K
40
$16K
41
$15K
42
$15K
43
$14K
44
$14K
45
$11K
46
$7K
47
$4K
48
$3K
49
$3K
50
$3K